HomeNewsBusinessMarketsMarket Week Ahead: 10 key factors that will keep traders busy

Market Week Ahead: 10 key factors that will keep traders busy

There could be some knee-jerk reactions on May 4 over weak global cues amid fears of another US-China trade war.

May 03, 2020 / 08:35 IST
Story continues below Advertisement

The market registered a strong run in the week that ended on April 30, majorly due to liquidity after global central banks announced stimulus measures.

The progress in COVID-19 vaccine, hopes of a bigger fiscal stimulus from the government, expectations of a decline in daily novel coronavirus cases in the United States and Europe, and partial reopening of economic activity also lifted the mood at Dalal Street.

Story continues below Advertisement

The BSE Sensex and Nifty50 gained nearly 8 percent each, taking the total April month's gains to more than 14 percent. The broader markets underperformed frontliners with the Nifty Midcap and Smallcap indices rising 6.35 percent and 3 percent, respectively.

However, the coming week is unexpected to be the same as there could be a knee-jerk reaction on May 4 (Monday) to weak global cues amid fears of another United States-China trade war and disappointing HUL earnings.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show